We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CREX icon
4726
Creative Realities
CREX
$39.3M
$7K ﹤0.01%
2,962
-436
-13% -$891
CRIS icon
4727
Curis
CRIS
$3.91M
$7K ﹤0.01%
29
-16
-36% -$4.22K
CWCO icon
4728
Consolidated Water Co
CWCO
$505M
$7K ﹤0.01%
450
-1,499
-77% -$22.3K
DBX icon
4729
Dropbox
DBX
$7.31B
$7K ﹤0.01%
319
-16,786
-98% -$368K
DJP icon
4730
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$814M
$7K ﹤0.01%
+231
New +$7.4K
DRMA icon
4731
Dermata Therapeutics
DRMA
$6.31M
$7K ﹤0.01%
39
+37
+1,850% +$21.6K
DUHP icon
4732
Dimensional US High Profitability ETF
DUHP
$12.8B
$7K ﹤0.01%
289
-39,805
-99% -$985K
DV icon
4733
DoubleVerify
DV
$2.04B
$7K ﹤0.01%
233
-7,559
-97% -$198K
DWX icon
4734
State Street SPDR S&P International Dividend ETF
DWX
$529M
$7K ﹤0.01%
200
-18
-8% -$611
FEMY icon
4735
Femasys
FEMY
$7.1M
$7K ﹤0.01%
334
-93
-22% -$2.14K
FINW icon
4736
FinWise Bancorp
FINW
$191M
$7K ﹤0.01%
759
+451
+146% +$4.11K
FOR icon
4737
Forestar Group
FOR
$1.49B
$7K ﹤0.01%
482
-32
-6% -$480
DMRA
4738
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.91B
$7K ﹤0.01%
142
-164
-54% -$8.65K
GOVX icon
4739
GeoVax Labs
GOVX
$3.74M
$7K ﹤0.01%
29
+11
+61% +$3.09K
HDB icon
4740
HDFC Bank
HDB
$119B
$7K ﹤0.01%
202
-4,236
-95% -$142K
IGC icon
4741
IGC Pharma
IGC
$30.7M
$7K ﹤0.01%
20,795
+10,703
+106% +$4.01K
IGHG icon
4742
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
$7K ﹤0.01%
100
+46
+85% +$3.31K
IHT
4743
InnSuites Hospitality Trust
IHT
$15.5M
$7K ﹤0.01%
5,246
+2,260
+76% +$3.71K
IMNM icon
4744
Immunome
IMNM
$3.18B
$7K ﹤0.01%
1,328
-1,030
-44% -$5.04K
IOR
4745
Income Opportunity Realty Investors
IOR
$7K ﹤0.01%
592
+168
+40% +$1.94K
IXN icon
4746
iShares Global Tech ETF
IXN
$9.47B
$7K ﹤0.01%
126
-1
-0.8% -$50
KWY
4747
Kingsway Corp
KWY
$279M
$7K ﹤0.01%
787
-999
-56% -$8.79K
KPLT icon
4748
Katapult Holdings
KPLT
$39.2M
$7K ﹤0.01%
618
+327
+112% +$7.1K
KRRO icon
4749
Korro Bio
KRRO
$197M
$7K ﹤0.01%
270
+212
+366% +$24.2K
LE icon
4750
Lands' End
LE
$391M
$7K ﹤0.01%
673
-790
-54% -$6.62K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.